Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor-Reference-Cited by-同舟云学术

Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor

Published:2018-03-25 Issue:5 Volume:9 Page:1224-1227
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Hamaguchi Tetsushi¹,Hirota Yushi¹^ORCID,Takeuchi Takehito¹,Nakagawa Yasushi¹,Matsuoka Atsuko¹,Matsumoto Masaaki²,Awano Hiroyuki²,Iijima Kazumoto²,Cha Pei Chieng³,Satake Wataru³,Toda Tatsushi³⁴,Ogawa Wataru¹

Affiliation:

1. Division of Diabetes and Endocrinology; Tokyo Japan

2. Department of Pediatrics; Kobe University Graduate School of Medicine; Kobe Japan

3. Division of Neurology; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan

4. Department of Neurology; Graduate School of Medicine; The University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12825/fullpdf

Reference12 articles.

1. Genetic syndromes of severe insulin resistance;Semple;Endocr Rev,2011

2. A family with severe insulin resistance and diabetes due to a mutation in AKT2;George;Science,2004

3. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy;Thauvin-Robinet;Am J Hum Genet,2013

4. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling;Chudasama;Am J Hum Genet,2013

5. Mutations in PIK3R1 cause SHORT syndrome;Dyment;Am J Hum Genet,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of genes involved in insulin metabolism in subcutaneous adipose tissue of pregnant women with and without polycystic ovary syndrome (PCOS);2024-08-18

2. A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02);Journal of Diabetes Investigation;2024-05-04

3. Diabetes mellitus with severe insulin resistance in a young male patient with a heterozygous pathogenic IRS1 frameshift variant;CLIN PEDIATR ENDOCRI;2024

4. A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01);Diabetes Therapy;2024-01-13

5. A Male Japanese Patient with Temple Syndrome Complicated by Type 2 Diabetes Mellitus;Internal Medicine;2024